Global Intravenous (IV) Iron Drugs Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Intravenous (IV) Iron Drugs Industry Forecast” looks at past sales and reviews total world Intravenous (IV) Iron Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Intravenous (IV) Iron Drugs sales for 2023 through 2029. With Intravenous (IV) Iron Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intravenous (IV) Iron Drugs industry.
This Insight Report provides a comprehensive analysis of the global Intravenous (IV) Iron Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intravenous (IV) Iron Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Intravenous (IV) Iron Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intravenous (IV) Iron Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intravenous (IV) Iron Drugs.
The global Intravenous (IV) Iron Drugs market size is projected to grow from US$ 1399.7 million in 2022 to US$ 1871.2 million in 2029; it is expected to grow at a CAGR of 1871.2 from 2023 to 2029.
United States market for Intravenous (IV) Iron Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Intravenous (IV) Iron Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Intravenous (IV) Iron Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Intravenous (IV) Iron Drugs players cover Sanofi US, Allergan, AMAG Pharmaceuticals, Dalichi Sankyo, Luitpold Pharmaceuticals, Pharmacosmos and Takeda Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous (IV) Iron Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Intravenous (IV) Iron Drugs market?
What factors are driving Intravenous (IV) Iron Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Intravenous (IV) Iron Drugs market opportunities vary by end market size?
How does Intravenous (IV) Iron Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Intravenous (IV) Iron Drugs Industry Forecast” looks at past sales and reviews total world Intravenous (IV) Iron Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Intravenous (IV) Iron Drugs sales for 2023 through 2029. With Intravenous (IV) Iron Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intravenous (IV) Iron Drugs industry.
This Insight Report provides a comprehensive analysis of the global Intravenous (IV) Iron Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intravenous (IV) Iron Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Intravenous (IV) Iron Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intravenous (IV) Iron Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intravenous (IV) Iron Drugs.
The global Intravenous (IV) Iron Drugs market size is projected to grow from US$ 1399.7 million in 2022 to US$ 1871.2 million in 2029; it is expected to grow at a CAGR of 1871.2 from 2023 to 2029.
United States market for Intravenous (IV) Iron Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Intravenous (IV) Iron Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Intravenous (IV) Iron Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Intravenous (IV) Iron Drugs players cover Sanofi US, Allergan, AMAG Pharmaceuticals, Dalichi Sankyo, Luitpold Pharmaceuticals, Pharmacosmos and Takeda Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous (IV) Iron Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Ferric Carboxymaltose
- Iron Sucrose
- Iron Dextran
- Others
- Nephrology
- Gynecology & Obstetrics
- Gastroenterology
- Oncology
- Cardiology
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi US
- Allergan
- AMAG Pharmaceuticals
- Dalichi Sankyo
- Luitpold Pharmaceuticals
- Pharmacosmos
- Takeda Pharmaceutical
What is the 10-year outlook for the global Intravenous (IV) Iron Drugs market?
What factors are driving Intravenous (IV) Iron Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Intravenous (IV) Iron Drugs market opportunities vary by end market size?
How does Intravenous (IV) Iron Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Intravenous (IV) Iron Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Intravenous (IV) Iron Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Intravenous (IV) Iron Drugs by Country/Region, 2018, 2022 & 2029
2.2 Intravenous (IV) Iron Drugs Segment by Type
2.2.1 Ferric Carboxymaltose
2.2.2 Iron Sucrose
2.2.3 Iron Dextran
2.2.4 Others
2.3 Intravenous (IV) Iron Drugs Sales by Type
2.3.1 Global Intravenous (IV) Iron Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Intravenous (IV) Iron Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Intravenous (IV) Iron Drugs Sale Price by Type (2018-2023)
2.4 Intravenous (IV) Iron Drugs Segment by Application
2.4.1 Nephrology
2.4.2 Gynecology & Obstetrics
2.4.3 Gastroenterology
2.4.4 Oncology
2.4.5 Cardiology
2.4.6 Others
2.5 Intravenous (IV) Iron Drugs Sales by Application
2.5.1 Global Intravenous (IV) Iron Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Intravenous (IV) Iron Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Intravenous (IV) Iron Drugs Sale Price by Application (2018-2023)
3 GLOBAL INTRAVENOUS (IV) IRON DRUGS BY COMPANY
3.1 Global Intravenous (IV) Iron Drugs Breakdown Data by Company
3.1.1 Global Intravenous (IV) Iron Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Intravenous (IV) Iron Drugs Sales Market Share by Company (2018-2023)
3.2 Global Intravenous (IV) Iron Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Intravenous (IV) Iron Drugs Revenue by Company (2018-2023)
3.2.2 Global Intravenous (IV) Iron Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Intravenous (IV) Iron Drugs Sale Price by Company
3.4 Key Manufacturers Intravenous (IV) Iron Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intravenous (IV) Iron Drugs Product Location Distribution
3.4.2 Players Intravenous (IV) Iron Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INTRAVENOUS (IV) IRON DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Intravenous (IV) Iron Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Intravenous (IV) Iron Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Intravenous (IV) Iron Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Intravenous (IV) Iron Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Intravenous (IV) Iron Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Intravenous (IV) Iron Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Intravenous (IV) Iron Drugs Sales Growth
4.4 APAC Intravenous (IV) Iron Drugs Sales Growth
4.5 Europe Intravenous (IV) Iron Drugs Sales Growth
4.6 Middle East & Africa Intravenous (IV) Iron Drugs Sales Growth
5 AMERICAS
5.1 Americas Intravenous (IV) Iron Drugs Sales by Country
5.1.1 Americas Intravenous (IV) Iron Drugs Sales by Country (2018-2023)
5.1.2 Americas Intravenous (IV) Iron Drugs Revenue by Country (2018-2023)
5.2 Americas Intravenous (IV) Iron Drugs Sales by Type
5.3 Americas Intravenous (IV) Iron Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intravenous (IV) Iron Drugs Sales by Region
6.1.1 APAC Intravenous (IV) Iron Drugs Sales by Region (2018-2023)
6.1.2 APAC Intravenous (IV) Iron Drugs Revenue by Region (2018-2023)
6.2 APAC Intravenous (IV) Iron Drugs Sales by Type
6.3 APAC Intravenous (IV) Iron Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Intravenous (IV) Iron Drugs by Country
7.1.1 Europe Intravenous (IV) Iron Drugs Sales by Country (2018-2023)
7.1.2 Europe Intravenous (IV) Iron Drugs Revenue by Country (2018-2023)
7.2 Europe Intravenous (IV) Iron Drugs Sales by Type
7.3 Europe Intravenous (IV) Iron Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Intravenous (IV) Iron Drugs by Country
8.1.1 Middle East & Africa Intravenous (IV) Iron Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Intravenous (IV) Iron Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Intravenous (IV) Iron Drugs Sales by Type
8.3 Middle East & Africa Intravenous (IV) Iron Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intravenous (IV) Iron Drugs
10.3 Manufacturing Process Analysis of Intravenous (IV) Iron Drugs
10.4 Industry Chain Structure of Intravenous (IV) Iron Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Intravenous (IV) Iron Drugs Distributors
11.3 Intravenous (IV) Iron Drugs Customer
12 WORLD FORECAST REVIEW FOR INTRAVENOUS (IV) IRON DRUGS BY GEOGRAPHIC REGION
12.1 Global Intravenous (IV) Iron Drugs Market Size Forecast by Region
12.1.1 Global Intravenous (IV) Iron Drugs Forecast by Region (2024-2029)
12.1.2 Global Intravenous (IV) Iron Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Intravenous (IV) Iron Drugs Forecast by Type
12.7 Global Intravenous (IV) Iron Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi US
13.1.1 Sanofi US Company Information
13.1.2 Sanofi US Intravenous (IV) Iron Drugs Product Portfolios and Specifications
13.1.3 Sanofi US Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Sanofi US Main Business Overview
13.1.5 Sanofi US Latest Developments
13.2 Allergan
13.2.1 Allergan Company Information
13.2.2 Allergan Intravenous (IV) Iron Drugs Product Portfolios and Specifications
13.2.3 Allergan Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Allergan Main Business Overview
13.2.5 Allergan Latest Developments
13.3 AMAG Pharmaceuticals
13.3.1 AMAG Pharmaceuticals Company Information
13.3.2 AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Product Portfolios and Specifications
13.3.3 AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 AMAG Pharmaceuticals Main Business Overview
13.3.5 AMAG Pharmaceuticals Latest Developments
13.4 Dalichi Sankyo
13.4.1 Dalichi Sankyo Company Information
13.4.2 Dalichi Sankyo Intravenous (IV) Iron Drugs Product Portfolios and Specifications
13.4.3 Dalichi Sankyo Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Dalichi Sankyo Main Business Overview
13.4.5 Dalichi Sankyo Latest Developments
13.5 Luitpold Pharmaceuticals
13.5.1 Luitpold Pharmaceuticals Company Information
13.5.2 Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Product Portfolios and Specifications
13.5.3 Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Luitpold Pharmaceuticals Main Business Overview
13.5.5 Luitpold Pharmaceuticals Latest Developments
13.6 Pharmacosmos
13.6.1 Pharmacosmos Company Information
13.6.2 Pharmacosmos Intravenous (IV) Iron Drugs Product Portfolios and Specifications
13.6.3 Pharmacosmos Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Pharmacosmos Main Business Overview
13.6.5 Pharmacosmos Latest Developments
13.7 Takeda Pharmaceutical
13.7.1 Takeda Pharmaceutical Company Information
13.7.2 Takeda Pharmaceutical Intravenous (IV) Iron Drugs Product Portfolios and Specifications
13.7.3 Takeda Pharmaceutical Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Takeda Pharmaceutical Main Business Overview
13.7.5 Takeda Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Intravenous (IV) Iron Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Intravenous (IV) Iron Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Intravenous (IV) Iron Drugs by Country/Region, 2018, 2022 & 2029
2.2 Intravenous (IV) Iron Drugs Segment by Type
2.2.1 Ferric Carboxymaltose
2.2.2 Iron Sucrose
2.2.3 Iron Dextran
2.2.4 Others
2.3 Intravenous (IV) Iron Drugs Sales by Type
2.3.1 Global Intravenous (IV) Iron Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Intravenous (IV) Iron Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Intravenous (IV) Iron Drugs Sale Price by Type (2018-2023)
2.4 Intravenous (IV) Iron Drugs Segment by Application
2.4.1 Nephrology
2.4.2 Gynecology & Obstetrics
2.4.3 Gastroenterology
2.4.4 Oncology
2.4.5 Cardiology
2.4.6 Others
2.5 Intravenous (IV) Iron Drugs Sales by Application
2.5.1 Global Intravenous (IV) Iron Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Intravenous (IV) Iron Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Intravenous (IV) Iron Drugs Sale Price by Application (2018-2023)
3 GLOBAL INTRAVENOUS (IV) IRON DRUGS BY COMPANY
3.1 Global Intravenous (IV) Iron Drugs Breakdown Data by Company
3.1.1 Global Intravenous (IV) Iron Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Intravenous (IV) Iron Drugs Sales Market Share by Company (2018-2023)
3.2 Global Intravenous (IV) Iron Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Intravenous (IV) Iron Drugs Revenue by Company (2018-2023)
3.2.2 Global Intravenous (IV) Iron Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Intravenous (IV) Iron Drugs Sale Price by Company
3.4 Key Manufacturers Intravenous (IV) Iron Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intravenous (IV) Iron Drugs Product Location Distribution
3.4.2 Players Intravenous (IV) Iron Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INTRAVENOUS (IV) IRON DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Intravenous (IV) Iron Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Intravenous (IV) Iron Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Intravenous (IV) Iron Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Intravenous (IV) Iron Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Intravenous (IV) Iron Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Intravenous (IV) Iron Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Intravenous (IV) Iron Drugs Sales Growth
4.4 APAC Intravenous (IV) Iron Drugs Sales Growth
4.5 Europe Intravenous (IV) Iron Drugs Sales Growth
4.6 Middle East & Africa Intravenous (IV) Iron Drugs Sales Growth
5 AMERICAS
5.1 Americas Intravenous (IV) Iron Drugs Sales by Country
5.1.1 Americas Intravenous (IV) Iron Drugs Sales by Country (2018-2023)
5.1.2 Americas Intravenous (IV) Iron Drugs Revenue by Country (2018-2023)
5.2 Americas Intravenous (IV) Iron Drugs Sales by Type
5.3 Americas Intravenous (IV) Iron Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intravenous (IV) Iron Drugs Sales by Region
6.1.1 APAC Intravenous (IV) Iron Drugs Sales by Region (2018-2023)
6.1.2 APAC Intravenous (IV) Iron Drugs Revenue by Region (2018-2023)
6.2 APAC Intravenous (IV) Iron Drugs Sales by Type
6.3 APAC Intravenous (IV) Iron Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Intravenous (IV) Iron Drugs by Country
7.1.1 Europe Intravenous (IV) Iron Drugs Sales by Country (2018-2023)
7.1.2 Europe Intravenous (IV) Iron Drugs Revenue by Country (2018-2023)
7.2 Europe Intravenous (IV) Iron Drugs Sales by Type
7.3 Europe Intravenous (IV) Iron Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Intravenous (IV) Iron Drugs by Country
8.1.1 Middle East & Africa Intravenous (IV) Iron Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Intravenous (IV) Iron Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Intravenous (IV) Iron Drugs Sales by Type
8.3 Middle East & Africa Intravenous (IV) Iron Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intravenous (IV) Iron Drugs
10.3 Manufacturing Process Analysis of Intravenous (IV) Iron Drugs
10.4 Industry Chain Structure of Intravenous (IV) Iron Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Intravenous (IV) Iron Drugs Distributors
11.3 Intravenous (IV) Iron Drugs Customer
12 WORLD FORECAST REVIEW FOR INTRAVENOUS (IV) IRON DRUGS BY GEOGRAPHIC REGION
12.1 Global Intravenous (IV) Iron Drugs Market Size Forecast by Region
12.1.1 Global Intravenous (IV) Iron Drugs Forecast by Region (2024-2029)
12.1.2 Global Intravenous (IV) Iron Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Intravenous (IV) Iron Drugs Forecast by Type
12.7 Global Intravenous (IV) Iron Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi US
13.1.1 Sanofi US Company Information
13.1.2 Sanofi US Intravenous (IV) Iron Drugs Product Portfolios and Specifications
13.1.3 Sanofi US Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Sanofi US Main Business Overview
13.1.5 Sanofi US Latest Developments
13.2 Allergan
13.2.1 Allergan Company Information
13.2.2 Allergan Intravenous (IV) Iron Drugs Product Portfolios and Specifications
13.2.3 Allergan Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Allergan Main Business Overview
13.2.5 Allergan Latest Developments
13.3 AMAG Pharmaceuticals
13.3.1 AMAG Pharmaceuticals Company Information
13.3.2 AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Product Portfolios and Specifications
13.3.3 AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 AMAG Pharmaceuticals Main Business Overview
13.3.5 AMAG Pharmaceuticals Latest Developments
13.4 Dalichi Sankyo
13.4.1 Dalichi Sankyo Company Information
13.4.2 Dalichi Sankyo Intravenous (IV) Iron Drugs Product Portfolios and Specifications
13.4.3 Dalichi Sankyo Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Dalichi Sankyo Main Business Overview
13.4.5 Dalichi Sankyo Latest Developments
13.5 Luitpold Pharmaceuticals
13.5.1 Luitpold Pharmaceuticals Company Information
13.5.2 Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Product Portfolios and Specifications
13.5.3 Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Luitpold Pharmaceuticals Main Business Overview
13.5.5 Luitpold Pharmaceuticals Latest Developments
13.6 Pharmacosmos
13.6.1 Pharmacosmos Company Information
13.6.2 Pharmacosmos Intravenous (IV) Iron Drugs Product Portfolios and Specifications
13.6.3 Pharmacosmos Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Pharmacosmos Main Business Overview
13.6.5 Pharmacosmos Latest Developments
13.7 Takeda Pharmaceutical
13.7.1 Takeda Pharmaceutical Company Information
13.7.2 Takeda Pharmaceutical Intravenous (IV) Iron Drugs Product Portfolios and Specifications
13.7.3 Takeda Pharmaceutical Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Takeda Pharmaceutical Main Business Overview
13.7.5 Takeda Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Intravenous (IV) Iron Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Intravenous (IV) Iron Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Ferric Carboxymaltose
Table 4. Major Players of Iron Sucrose
Table 5. Major Players of Iron Dextran
Table 6. Major Players of Others
Table 7. Global Intravenous (IV) Iron Drugs Sales by Type (2018-2023) & (K Units)
Table 8. Global Intravenous (IV) Iron Drugs Sales Market Share by Type (2018-2023)
Table 9. Global Intravenous (IV) Iron Drugs Revenue by Type (2018-2023) & ($ million)
Table 10. Global Intravenous (IV) Iron Drugs Revenue Market Share by Type (2018-2023)
Table 11. Global Intravenous (IV) Iron Drugs Sale Price by Type (2018-2023) & (USD/Unit)
Table 12. Global Intravenous (IV) Iron Drugs Sales by Application (2018-2023) & (K Units)
Table 13. Global Intravenous (IV) Iron Drugs Sales Market Share by Application (2018-2023)
Table 14. Global Intravenous (IV) Iron Drugs Revenue by Application (2018-2023)
Table 15. Global Intravenous (IV) Iron Drugs Revenue Market Share by Application (2018-2023)
Table 16. Global Intravenous (IV) Iron Drugs Sale Price by Application (2018-2023) & (USD/Unit)
Table 17. Global Intravenous (IV) Iron Drugs Sales by Company (2018-2023) & (K Units)
Table 18. Global Intravenous (IV) Iron Drugs Sales Market Share by Company (2018-2023)
Table 19. Global Intravenous (IV) Iron Drugs Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Intravenous (IV) Iron Drugs Revenue Market Share by Company (2018-2023)
Table 21. Global Intravenous (IV) Iron Drugs Sale Price by Company (2018-2023) & (USD/Unit)
Table 22. Key Manufacturers Intravenous (IV) Iron Drugs Producing Area Distribution and Sales Area
Table 23. Players Intravenous (IV) Iron Drugs Products Offered
Table 24. Intravenous (IV) Iron Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Intravenous (IV) Iron Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Intravenous (IV) Iron Drugs Sales Market Share Geographic Region (2018-2023)
Table 29. Global Intravenous (IV) Iron Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Intravenous (IV) Iron Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Intravenous (IV) Iron Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Intravenous (IV) Iron Drugs Sales Market Share by Country/Region (2018-2023)
Table 33. Global Intravenous (IV) Iron Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Intravenous (IV) Iron Drugs Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Intravenous (IV) Iron Drugs Sales by Country (2018-2023) & (K Units)
Table 36. Americas Intravenous (IV) Iron Drugs Sales Market Share by Country (2018-2023)
Table 37. Americas Intravenous (IV) Iron Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Intravenous (IV) Iron Drugs Revenue Market Share by Country (2018-2023)
Table 39. Americas Intravenous (IV) Iron Drugs Sales by Type (2018-2023) & (K Units)
Table 40. Americas Intravenous (IV) Iron Drugs Sales by Application (2018-2023) & (K Units)
Table 41. APAC Intravenous (IV) Iron Drugs Sales by Region (2018-2023) & (K Units)
Table 42. APAC Intravenous (IV) Iron Drugs Sales Market Share by Region (2018-2023)
Table 43. APAC Intravenous (IV) Iron Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Intravenous (IV) Iron Drugs Revenue Market Share by Region (2018-2023)
Table 45. APAC Intravenous (IV) Iron Drugs Sales by Type (2018-2023) & (K Units)
Table 46. APAC Intravenous (IV) Iron Drugs Sales by Application (2018-2023) & (K Units)
Table 47. Europe Intravenous (IV) Iron Drugs Sales by Country (2018-2023) & (K Units)
Table 48. Europe Intravenous (IV) Iron Drugs Sales Market Share by Country (2018-2023)
Table 49. Europe Intravenous (IV) Iron Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Intravenous (IV) Iron Drugs Revenue Market Share by Country (2018-2023)
Table 51. Europe Intravenous (IV) Iron Drugs Sales by Type (2018-2023) & (K Units)
Table 52. Europe Intravenous (IV) Iron Drugs Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Intravenous (IV) Iron Drugs Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Intravenous (IV) Iron Drugs Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Intravenous (IV) Iron Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Intravenous (IV) Iron Drugs Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Intravenous (IV) Iron Drugs Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Intravenous (IV) Iron Drugs Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Intravenous (IV) Iron Drugs
Table 60. Key Market Challenges & Risks of Intravenous (IV) Iron Drugs
Table 61. Key Industry Trends of Intravenous (IV) Iron Drugs
Table 62. Intravenous (IV) Iron Drugs Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Intravenous (IV) Iron Drugs Distributors List
Table 65. Intravenous (IV) Iron Drugs Customer List
Table 66. Global Intravenous (IV) Iron Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Intravenous (IV) Iron Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Intravenous (IV) Iron Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Intravenous (IV) Iron Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Intravenous (IV) Iron Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Intravenous (IV) Iron Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Intravenous (IV) Iron Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Intravenous (IV) Iron Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Intravenous (IV) Iron Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Intravenous (IV) Iron Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Intravenous (IV) Iron Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Intravenous (IV) Iron Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Intravenous (IV) Iron Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Intravenous (IV) Iron Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Sanofi US Basic Information, Intravenous (IV) Iron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Sanofi US Intravenous (IV) Iron Drugs Product Portfolios and Specifications
Table 82. Sanofi US Intravenous (IV) Iron Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Sanofi US Main Business
Table 84. Sanofi US Latest Developments
Table 85. Allergan Basic Information, Intravenous (IV) Iron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Allergan Intravenous (IV) Iron Drugs Product Portfolios and Specifications
Table 87. Allergan Intravenous (IV) Iron Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Allergan Main Business
Table 89. Allergan Latest Developments
Table 90. AMAG Pharmaceuticals Basic Information, Intravenous (IV) Iron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Product Portfolios and Specifications
Table 92. AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. AMAG Pharmaceuticals Main Business
Table 94. AMAG Pharmaceuticals Latest Developments
Table 95. Dalichi Sankyo Basic Information, Intravenous (IV) Iron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Dalichi Sankyo Intravenous (IV) Iron Drugs Product Portfolios and Specifications
Table 97. Dalichi Sankyo Intravenous (IV) Iron Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Dalichi Sankyo Main Business
Table 99. Dalichi Sankyo Latest Developments
Table 100. Luitpold Pharmaceuticals Basic Information, Intravenous (IV) Iron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Product Portfolios and Specifications
Table 102. Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Luitpold Pharmaceuticals Main Business
Table 104. Luitpold Pharmaceuticals Latest Developments
Table 105. Pharmacosmos Basic Information, Intravenous (IV) Iron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Pharmacosmos Intravenous (IV) Iron Drugs Product Portfolios and Specifications
Table 107. Pharmacosmos Intravenous (IV) Iron Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Pharmacosmos Main Business
Table 109. Pharmacosmos Latest Developments
Table 110. Takeda Pharmaceutical Basic Information, Intravenous (IV) Iron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Takeda Pharmaceutical Intravenous (IV) Iron Drugs Product Portfolios and Specifications
Table 112. Takeda Pharmaceutical Intravenous (IV) Iron Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Takeda Pharmaceutical Main Business
Table 114. Takeda Pharmaceutical Latest Developments
Table 1. Intravenous (IV) Iron Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Intravenous (IV) Iron Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Ferric Carboxymaltose
Table 4. Major Players of Iron Sucrose
Table 5. Major Players of Iron Dextran
Table 6. Major Players of Others
Table 7. Global Intravenous (IV) Iron Drugs Sales by Type (2018-2023) & (K Units)
Table 8. Global Intravenous (IV) Iron Drugs Sales Market Share by Type (2018-2023)
Table 9. Global Intravenous (IV) Iron Drugs Revenue by Type (2018-2023) & ($ million)
Table 10. Global Intravenous (IV) Iron Drugs Revenue Market Share by Type (2018-2023)
Table 11. Global Intravenous (IV) Iron Drugs Sale Price by Type (2018-2023) & (USD/Unit)
Table 12. Global Intravenous (IV) Iron Drugs Sales by Application (2018-2023) & (K Units)
Table 13. Global Intravenous (IV) Iron Drugs Sales Market Share by Application (2018-2023)
Table 14. Global Intravenous (IV) Iron Drugs Revenue by Application (2018-2023)
Table 15. Global Intravenous (IV) Iron Drugs Revenue Market Share by Application (2018-2023)
Table 16. Global Intravenous (IV) Iron Drugs Sale Price by Application (2018-2023) & (USD/Unit)
Table 17. Global Intravenous (IV) Iron Drugs Sales by Company (2018-2023) & (K Units)
Table 18. Global Intravenous (IV) Iron Drugs Sales Market Share by Company (2018-2023)
Table 19. Global Intravenous (IV) Iron Drugs Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Intravenous (IV) Iron Drugs Revenue Market Share by Company (2018-2023)
Table 21. Global Intravenous (IV) Iron Drugs Sale Price by Company (2018-2023) & (USD/Unit)
Table 22. Key Manufacturers Intravenous (IV) Iron Drugs Producing Area Distribution and Sales Area
Table 23. Players Intravenous (IV) Iron Drugs Products Offered
Table 24. Intravenous (IV) Iron Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Intravenous (IV) Iron Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Intravenous (IV) Iron Drugs Sales Market Share Geographic Region (2018-2023)
Table 29. Global Intravenous (IV) Iron Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Intravenous (IV) Iron Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Intravenous (IV) Iron Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Intravenous (IV) Iron Drugs Sales Market Share by Country/Region (2018-2023)
Table 33. Global Intravenous (IV) Iron Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Intravenous (IV) Iron Drugs Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Intravenous (IV) Iron Drugs Sales by Country (2018-2023) & (K Units)
Table 36. Americas Intravenous (IV) Iron Drugs Sales Market Share by Country (2018-2023)
Table 37. Americas Intravenous (IV) Iron Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Intravenous (IV) Iron Drugs Revenue Market Share by Country (2018-2023)
Table 39. Americas Intravenous (IV) Iron Drugs Sales by Type (2018-2023) & (K Units)
Table 40. Americas Intravenous (IV) Iron Drugs Sales by Application (2018-2023) & (K Units)
Table 41. APAC Intravenous (IV) Iron Drugs Sales by Region (2018-2023) & (K Units)
Table 42. APAC Intravenous (IV) Iron Drugs Sales Market Share by Region (2018-2023)
Table 43. APAC Intravenous (IV) Iron Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Intravenous (IV) Iron Drugs Revenue Market Share by Region (2018-2023)
Table 45. APAC Intravenous (IV) Iron Drugs Sales by Type (2018-2023) & (K Units)
Table 46. APAC Intravenous (IV) Iron Drugs Sales by Application (2018-2023) & (K Units)
Table 47. Europe Intravenous (IV) Iron Drugs Sales by Country (2018-2023) & (K Units)
Table 48. Europe Intravenous (IV) Iron Drugs Sales Market Share by Country (2018-2023)
Table 49. Europe Intravenous (IV) Iron Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Intravenous (IV) Iron Drugs Revenue Market Share by Country (2018-2023)
Table 51. Europe Intravenous (IV) Iron Drugs Sales by Type (2018-2023) & (K Units)
Table 52. Europe Intravenous (IV) Iron Drugs Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Intravenous (IV) Iron Drugs Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Intravenous (IV) Iron Drugs Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Intravenous (IV) Iron Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Intravenous (IV) Iron Drugs Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Intravenous (IV) Iron Drugs Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Intravenous (IV) Iron Drugs Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Intravenous (IV) Iron Drugs
Table 60. Key Market Challenges & Risks of Intravenous (IV) Iron Drugs
Table 61. Key Industry Trends of Intravenous (IV) Iron Drugs
Table 62. Intravenous (IV) Iron Drugs Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Intravenous (IV) Iron Drugs Distributors List
Table 65. Intravenous (IV) Iron Drugs Customer List
Table 66. Global Intravenous (IV) Iron Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Intravenous (IV) Iron Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Intravenous (IV) Iron Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Intravenous (IV) Iron Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Intravenous (IV) Iron Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Intravenous (IV) Iron Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Intravenous (IV) Iron Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Intravenous (IV) Iron Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Intravenous (IV) Iron Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Intravenous (IV) Iron Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Intravenous (IV) Iron Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Intravenous (IV) Iron Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Intravenous (IV) Iron Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Intravenous (IV) Iron Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Sanofi US Basic Information, Intravenous (IV) Iron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Sanofi US Intravenous (IV) Iron Drugs Product Portfolios and Specifications
Table 82. Sanofi US Intravenous (IV) Iron Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Sanofi US Main Business
Table 84. Sanofi US Latest Developments
Table 85. Allergan Basic Information, Intravenous (IV) Iron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Allergan Intravenous (IV) Iron Drugs Product Portfolios and Specifications
Table 87. Allergan Intravenous (IV) Iron Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Allergan Main Business
Table 89. Allergan Latest Developments
Table 90. AMAG Pharmaceuticals Basic Information, Intravenous (IV) Iron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Product Portfolios and Specifications
Table 92. AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. AMAG Pharmaceuticals Main Business
Table 94. AMAG Pharmaceuticals Latest Developments
Table 95. Dalichi Sankyo Basic Information, Intravenous (IV) Iron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Dalichi Sankyo Intravenous (IV) Iron Drugs Product Portfolios and Specifications
Table 97. Dalichi Sankyo Intravenous (IV) Iron Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Dalichi Sankyo Main Business
Table 99. Dalichi Sankyo Latest Developments
Table 100. Luitpold Pharmaceuticals Basic Information, Intravenous (IV) Iron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Product Portfolios and Specifications
Table 102. Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Luitpold Pharmaceuticals Main Business
Table 104. Luitpold Pharmaceuticals Latest Developments
Table 105. Pharmacosmos Basic Information, Intravenous (IV) Iron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Pharmacosmos Intravenous (IV) Iron Drugs Product Portfolios and Specifications
Table 107. Pharmacosmos Intravenous (IV) Iron Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Pharmacosmos Main Business
Table 109. Pharmacosmos Latest Developments
Table 110. Takeda Pharmaceutical Basic Information, Intravenous (IV) Iron Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Takeda Pharmaceutical Intravenous (IV) Iron Drugs Product Portfolios and Specifications
Table 112. Takeda Pharmaceutical Intravenous (IV) Iron Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Takeda Pharmaceutical Main Business
Table 114. Takeda Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Intravenous (IV) Iron Drugs
Figure 2. Intravenous (IV) Iron Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intravenous (IV) Iron Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Intravenous (IV) Iron Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Intravenous (IV) Iron Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Ferric Carboxymaltose
Figure 10. Product Picture of Iron Sucrose
Figure 11. Product Picture of Iron Dextran
Figure 12. Product Picture of Others
Figure 13. Global Intravenous (IV) Iron Drugs Sales Market Share by Type in 2022
Figure 14. Global Intravenous (IV) Iron Drugs Revenue Market Share by Type (2018-2023)
Figure 15. Intravenous (IV) Iron Drugs Consumed in Nephrology
Figure 16. Global Intravenous (IV) Iron Drugs Market: Nephrology (2018-2023) & (K Units)
Figure 17. Intravenous (IV) Iron Drugs Consumed in Gynecology & Obstetrics
Figure 18. Global Intravenous (IV) Iron Drugs Market: Gynecology & Obstetrics (2018-2023) & (K Units)
Figure 19. Intravenous (IV) Iron Drugs Consumed in Gastroenterology
Figure 20. Global Intravenous (IV) Iron Drugs Market: Gastroenterology (2018-2023) & (K Units)
Figure 21. Intravenous (IV) Iron Drugs Consumed in Oncology
Figure 22. Global Intravenous (IV) Iron Drugs Market: Oncology (2018-2023) & (K Units)
Figure 23. Intravenous (IV) Iron Drugs Consumed in Cardiology
Figure 24. Global Intravenous (IV) Iron Drugs Market: Cardiology (2018-2023) & (K Units)
Figure 25. Intravenous (IV) Iron Drugs Consumed in Others
Figure 26. Global Intravenous (IV) Iron Drugs Market: Others (2018-2023) & (K Units)
Figure 27. Global Intravenous (IV) Iron Drugs Sales Market Share by Application (2022)
Figure 28. Global Intravenous (IV) Iron Drugs Revenue Market Share by Application in 2022
Figure 29. Intravenous (IV) Iron Drugs Sales Market by Company in 2022 (K Units)
Figure 30. Global Intravenous (IV) Iron Drugs Sales Market Share by Company in 2022
Figure 31. Intravenous (IV) Iron Drugs Revenue Market by Company in 2022 ($ Million)
Figure 32. Global Intravenous (IV) Iron Drugs Revenue Market Share by Company in 2022
Figure 33. Global Intravenous (IV) Iron Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 34. Global Intravenous (IV) Iron Drugs Revenue Market Share by Geographic Region in 2022
Figure 35. Americas Intravenous (IV) Iron Drugs Sales 2018-2023 (K Units)
Figure 36. Americas Intravenous (IV) Iron Drugs Revenue 2018-2023 ($ Millions)
Figure 37. APAC Intravenous (IV) Iron Drugs Sales 2018-2023 (K Units)
Figure 38. APAC Intravenous (IV) Iron Drugs Revenue 2018-2023 ($ Millions)
Figure 39. Europe Intravenous (IV) Iron Drugs Sales 2018-2023 (K Units)
Figure 40. Europe Intravenous (IV) Iron Drugs Revenue 2018-2023 ($ Millions)
Figure 41. Middle East & Africa Intravenous (IV) Iron Drugs Sales 2018-2023 (K Units)
Figure 42. Middle East & Africa Intravenous (IV) Iron Drugs Revenue 2018-2023 ($ Millions)
Figure 43. Americas Intravenous (IV) Iron Drugs Sales Market Share by Country in 2022
Figure 44. Americas Intravenous (IV) Iron Drugs Revenue Market Share by Country in 2022
Figure 45. Americas Intravenous (IV) Iron Drugs Sales Market Share by Type (2018-2023)
Figure 46. Americas Intravenous (IV) Iron Drugs Sales Market Share by Application (2018-2023)
Figure 47. United States Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 48. Canada Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 49. Mexico Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 50. Brazil Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 51. APAC Intravenous (IV) Iron Drugs Sales Market Share by Region in 2022
Figure 52. APAC Intravenous (IV) Iron Drugs Revenue Market Share by Regions in 2022
Figure 53. APAC Intravenous (IV) Iron Drugs Sales Market Share by Type (2018-2023)
Figure 54. APAC Intravenous (IV) Iron Drugs Sales Market Share by Application (2018-2023)
Figure 55. China Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 56. Japan Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 57. South Korea Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 58. Southeast Asia Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 59. India Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 60. Australia Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 61. China Taiwan Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 62. Europe Intravenous (IV) Iron Drugs Sales Market Share by Country in 2022
Figure 63. Europe Intravenous (IV) Iron Drugs Revenue Market Share by Country in 2022
Figure 64. Europe Intravenous (IV) Iron Drugs Sales Market Share by Type (2018-2023)
Figure 65. Europe Intravenous (IV) Iron Drugs Sales Market Share by Application (2018-2023)
Figure 66. Germany Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 67. France Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 68. UK Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 69. Italy Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 70. Russia Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 71. Middle East & Africa Intravenous (IV) Iron Drugs Sales Market Share by Country in 2022
Figure 72. Middle East & Africa Intravenous (IV) Iron Drugs Revenue Market Share by Country in 2022
Figure 73. Middle East & Africa Intravenous (IV) Iron Drugs Sales Market Share by Type (2018-2023)
Figure 74. Middle East & Africa Intravenous (IV) Iron Drugs Sales Market Share by Application (2018-2023)
Figure 75. Egypt Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 76. South Africa Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 77. Israel Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 78. Turkey Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 79. GCC Country Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 80. Manufacturing Cost Structure Analysis of Intravenous (IV) Iron Drugs in 2022
Figure 81. Manufacturing Process Analysis of Intravenous (IV) Iron Drugs
Figure 82. Industry Chain Structure of Intravenous (IV) Iron Drugs
Figure 83. Channels of Distribution
Figure 84. Global Intravenous (IV) Iron Drugs Sales Market Forecast by Region (2024-2029)
Figure 85. Global Intravenous (IV) Iron Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 86. Global Intravenous (IV) Iron Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 87. Global Intravenous (IV) Iron Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 88. Global Intravenous (IV) Iron Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 89. Global Intravenous (IV) Iron Drugs Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Intravenous (IV) Iron Drugs
Figure 2. Intravenous (IV) Iron Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intravenous (IV) Iron Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Intravenous (IV) Iron Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Intravenous (IV) Iron Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Ferric Carboxymaltose
Figure 10. Product Picture of Iron Sucrose
Figure 11. Product Picture of Iron Dextran
Figure 12. Product Picture of Others
Figure 13. Global Intravenous (IV) Iron Drugs Sales Market Share by Type in 2022
Figure 14. Global Intravenous (IV) Iron Drugs Revenue Market Share by Type (2018-2023)
Figure 15. Intravenous (IV) Iron Drugs Consumed in Nephrology
Figure 16. Global Intravenous (IV) Iron Drugs Market: Nephrology (2018-2023) & (K Units)
Figure 17. Intravenous (IV) Iron Drugs Consumed in Gynecology & Obstetrics
Figure 18. Global Intravenous (IV) Iron Drugs Market: Gynecology & Obstetrics (2018-2023) & (K Units)
Figure 19. Intravenous (IV) Iron Drugs Consumed in Gastroenterology
Figure 20. Global Intravenous (IV) Iron Drugs Market: Gastroenterology (2018-2023) & (K Units)
Figure 21. Intravenous (IV) Iron Drugs Consumed in Oncology
Figure 22. Global Intravenous (IV) Iron Drugs Market: Oncology (2018-2023) & (K Units)
Figure 23. Intravenous (IV) Iron Drugs Consumed in Cardiology
Figure 24. Global Intravenous (IV) Iron Drugs Market: Cardiology (2018-2023) & (K Units)
Figure 25. Intravenous (IV) Iron Drugs Consumed in Others
Figure 26. Global Intravenous (IV) Iron Drugs Market: Others (2018-2023) & (K Units)
Figure 27. Global Intravenous (IV) Iron Drugs Sales Market Share by Application (2022)
Figure 28. Global Intravenous (IV) Iron Drugs Revenue Market Share by Application in 2022
Figure 29. Intravenous (IV) Iron Drugs Sales Market by Company in 2022 (K Units)
Figure 30. Global Intravenous (IV) Iron Drugs Sales Market Share by Company in 2022
Figure 31. Intravenous (IV) Iron Drugs Revenue Market by Company in 2022 ($ Million)
Figure 32. Global Intravenous (IV) Iron Drugs Revenue Market Share by Company in 2022
Figure 33. Global Intravenous (IV) Iron Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 34. Global Intravenous (IV) Iron Drugs Revenue Market Share by Geographic Region in 2022
Figure 35. Americas Intravenous (IV) Iron Drugs Sales 2018-2023 (K Units)
Figure 36. Americas Intravenous (IV) Iron Drugs Revenue 2018-2023 ($ Millions)
Figure 37. APAC Intravenous (IV) Iron Drugs Sales 2018-2023 (K Units)
Figure 38. APAC Intravenous (IV) Iron Drugs Revenue 2018-2023 ($ Millions)
Figure 39. Europe Intravenous (IV) Iron Drugs Sales 2018-2023 (K Units)
Figure 40. Europe Intravenous (IV) Iron Drugs Revenue 2018-2023 ($ Millions)
Figure 41. Middle East & Africa Intravenous (IV) Iron Drugs Sales 2018-2023 (K Units)
Figure 42. Middle East & Africa Intravenous (IV) Iron Drugs Revenue 2018-2023 ($ Millions)
Figure 43. Americas Intravenous (IV) Iron Drugs Sales Market Share by Country in 2022
Figure 44. Americas Intravenous (IV) Iron Drugs Revenue Market Share by Country in 2022
Figure 45. Americas Intravenous (IV) Iron Drugs Sales Market Share by Type (2018-2023)
Figure 46. Americas Intravenous (IV) Iron Drugs Sales Market Share by Application (2018-2023)
Figure 47. United States Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 48. Canada Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 49. Mexico Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 50. Brazil Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 51. APAC Intravenous (IV) Iron Drugs Sales Market Share by Region in 2022
Figure 52. APAC Intravenous (IV) Iron Drugs Revenue Market Share by Regions in 2022
Figure 53. APAC Intravenous (IV) Iron Drugs Sales Market Share by Type (2018-2023)
Figure 54. APAC Intravenous (IV) Iron Drugs Sales Market Share by Application (2018-2023)
Figure 55. China Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 56. Japan Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 57. South Korea Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 58. Southeast Asia Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 59. India Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 60. Australia Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 61. China Taiwan Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 62. Europe Intravenous (IV) Iron Drugs Sales Market Share by Country in 2022
Figure 63. Europe Intravenous (IV) Iron Drugs Revenue Market Share by Country in 2022
Figure 64. Europe Intravenous (IV) Iron Drugs Sales Market Share by Type (2018-2023)
Figure 65. Europe Intravenous (IV) Iron Drugs Sales Market Share by Application (2018-2023)
Figure 66. Germany Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 67. France Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 68. UK Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 69. Italy Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 70. Russia Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 71. Middle East & Africa Intravenous (IV) Iron Drugs Sales Market Share by Country in 2022
Figure 72. Middle East & Africa Intravenous (IV) Iron Drugs Revenue Market Share by Country in 2022
Figure 73. Middle East & Africa Intravenous (IV) Iron Drugs Sales Market Share by Type (2018-2023)
Figure 74. Middle East & Africa Intravenous (IV) Iron Drugs Sales Market Share by Application (2018-2023)
Figure 75. Egypt Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 76. South Africa Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 77. Israel Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 78. Turkey Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 79. GCC Country Intravenous (IV) Iron Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 80. Manufacturing Cost Structure Analysis of Intravenous (IV) Iron Drugs in 2022
Figure 81. Manufacturing Process Analysis of Intravenous (IV) Iron Drugs
Figure 82. Industry Chain Structure of Intravenous (IV) Iron Drugs
Figure 83. Channels of Distribution
Figure 84. Global Intravenous (IV) Iron Drugs Sales Market Forecast by Region (2024-2029)
Figure 85. Global Intravenous (IV) Iron Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 86. Global Intravenous (IV) Iron Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 87. Global Intravenous (IV) Iron Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 88. Global Intravenous (IV) Iron Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 89. Global Intravenous (IV) Iron Drugs Revenue Market Share Forecast by Application (2024-2029)
